Iterum Therapeutics PLC Sustainability Reports
Iterum Therapeutics PLC is a pharmaceutical company focused on the development and commercialization of treatments for multi-drug resistant bacterial infections. Its primary product is Orlynvah (oral sulopenem) for the treatment of uncomplicated urinary tract infections.
Sector: Manufacturing
Country: Ireland
Exchange: Nasdaq
1 reports from 2018 to 2018
Company Profile
Iterum Therapeutics PLC is a pharmaceutical company focused on the development and commercialization of treatments for multi-drug resistant bacterial infections. Its primary product is Orlynvah (oral sulopenem) for the treatment of uncomplicated urinary tract infections.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
